Latest filing published 06 Jan 2020 for Bellicum Pharmaceuticals, INC.
Filing timeline
BuySaleInsider track record
Alan K. Smith: trading record in brief
Alan K. Smith discloses dealings in Bellicum Pharmaceuticals, Inc to SEC (Form 4). Over a trading history stretching from 24 July 2017 to 3 January 2020, the count stands at 12 filings.
On the market, this insider has only sold: 2 sales, €8,274 in total. Besides market trades, the filings include 5 share grants and 5 option exercises.
The record was last updated on 6 January 2020 with a share grant (€738) in Bellicum Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alan K. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,344 sharesCommon StockSEC:0001705246-20-000002:0
- 1,563 sharesCommon StockSEC:0001705246-20-000002:2
- 883 shares@ US$1.5119.3% of flowCommon StockSEC:0001705246-20-000002:1
- 589 shares@ US$1.4012.0% of flowCommon StockSEC:0001705246-20-000002:3
- 2,344 sharesCommon StockSEC:0001358403-19-000006:0
- 1,562 sharesCommon StockSEC:0001358403-19-000006:2
- 883 shares@ US$3.3317.4% of flowCommon StockSEC:0001358403-19-000006:1
- 589 shares@ US$3.2011.3% of flowCommon StockSEC:0001358403-19-000006:3
- 487 shares@ US$9.4019.9% of flowCommon StockSEC:0001358403-18-000020:0
- 1,563 sharesCommon StockSEC:0001358403-18-000016:0
- 589 shares@ US$9.7924.9% of flowCommon StockSEC:0001358403-18-000016:1
- 437 shares@ US$11.8523.2% of flowCommon StockSEC:0001358403-17-000142:0
12 of 12 declarations
